Elizabeth Delzell, Sc.D.
Principal Scientist
Health Sciences
  • Alexandria, VA

Dr. Delzell has extensive experience in occupational and environmental epidemiology and in pharmacoepidemiology. She has conducted research on health effects related to butadiene, styrene, benzene, pesticides, dioxins, acrylonitrile, glycol ethers, talc, and other exposures. She is an expert on the conduct and interpretation of studies of the safety and effectiveness of pharmaceutical agents, particularly agents used to treat immune-mediated disease, osteoporosis, and fragility fractures. She is experienced in providing litigation support and conducting comprehensive reviews and interpretation of science for litigation and for regulatory processes.

Dr. Delzell received the Sc.D. from Harvard University in 1981. She subsequently served on the faculties of the University of Alabama at Birmingham and Duke University. As a professor of epidemiology, she taught and conducted training in occupational and environmental epidemiology, cancer epidemiology, and pharmacoepidemiology and was a reviewer, advisory panel member, or expert for NIOSH, NCI, NIEHS, ATSDR, the NTP, the Health Effects Institute, and the International Agency for Research on Cancer. Her research has included large studies of chronic disease among workers in the motor vehicle, microelectronics, rubber products, and petrochemical industries, as well as evaluations of cancer clusters in industrial and community settings. For the past 10 years, she also has conducted studies that used Medicare and other medical insurance claims data to carry out pharmacovigilance research and to evaluate the utilization, safety and comparative effectiveness of biological agents and other drugs used to treat osteoporosis, rheumatoid arthritis and other immune-mediated conditions. Her research also has evaluated the utilization of statins and other lipid-lowering drugs.

CREDENTIALS & PROFESSIONAL HONORS

  • Sc.D., Epidemiology, Harvard University, 1981
  • M.S.P.H., Epidemiology, University of North Carolina, Chapel Hill, 1977
  • B.S., Biology, Oakland University, 1974

Publications

Chang ET, Delzell E. Systematic review and meta-analysis of glyphosate exposure and risk of lymphohematopoietic cancers. Journal of Environmental Science and Health. Part B, 2016, in press.

Colantonio LD, Kent ST, Kilgore ML, Delzell E, Curtis JR, Howard G, Safford MM, Muntner P. Agreement between Medicare pharmacy claims, self-report and medication inventory for assessing lipid-lowering medication use. Pharmacoepidemiology and Drug Safety 2016, in press.

Yun H, Xie F, Delzell E, Levitan EB, Chen L, Lewis JD, Saag KG, Beukelman T, Winthrop KL, Baddley JW, Curtis JR. Comparative risk of hospitalized infection associated with biological agents among rheumatoid arthritis patients enrolled in Medicare. Arthritis & Rheumatology 2016; 68:56-66.

Sathiakumar N, Brill I, Leader M, Delzell E. 1,3-Butadiene, styrene and lymphohematopoietic cancer among male synthetic rubber industry workers – Preliminary exposure-response analyses. Chemico-biological Interactions 2015; 241:40-49.

Yun H, Xie F, Delzell E, Chen L, Yang S, Saag KG, Joseph GJ, Harrison DJ, Curtis J. The comparative effectiveness of biologics among older adults and disabled rheumatoid arthritis patients in the Medicare population. British Journal of Clinical Pharmacology 2015; 80:1447-1457.

Wright NC, Curtis JR, Arora T, Smith WK, Kilgore ML, Saag KG, Safford MM, Delzell ES. The validity of claims-based algorithms to identify serious hypersensitivity reactions and osteonecrosis of the jaw. PLoS One 2015 Jul 10;10(7):e0131601. doi: 10.1371/journal.pone.0131601. eCollection 2015.

Osterman MT, Haynes K, Delzell E, Zhang J, Bewtra M, Brensinger CM, Chen L, Xie F, Curtis JR, Lewis JD. Effectiveness and safety of immunomodulators with anti-TNF therapy in Crohn's disease. Clinical Gastroenterology and Hepatology 2015; 13:1293-1301.

Curtis JR, Xie F, Yun H, Saag KG, Chen L, Delzell E. Risk of hospitalized infection among biologic-treated rheumatoid arthritis patients concurrently using denosumab. Arthritis & Rheumatology 2015; 67:1456-1464.

Yun H, Safford M, Brown TM, Farkouh ME, Kent S, Sharma P, Kilgore M, Bittner V, Rosenson R, Delzell E, Muntner P, Levitan E. Statin use following hospitalization among Medicare beneficiaries with a secondary discharge diagnosis of acute myocardial infarction. Journal of the American Heart Association, 2015 Feb 9;4(2). pii: e001208. doi: 10.1161/JAHA.114.001208.

Navarro-Millán I, Yang S, DuVall SL, Chen L, Baddley J, Cannon GW, Delzell ES, Zhang J, Safford MM, Patkar NM, Mikuls TR, Singh JA, Curtis JR. Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Annals of the Rheumatic Diseases. 2015 Jan 21. pii: annrheumdis-2013-204987. doi: 10.1136/annrheumdis-2013-204987. [Epub ahead of print]

Zhang J, Xie F, Delzell E, Yun H, Lewis JD, Haynes K, Chen L, Beukelman T, Saag KG, Curtis JR. Impact of biologics agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients. Arthritis Care & Research 2015; 67:624-632.

Yun H, Xie F, Delzell E, Chen L, Levitan EB, Lewis JD, Saag KG, Beukelman T, Winthrop K, Baddley JW, Curtis JR. Risks of Herpes zoster in patients with rheumatoid arthritis according to biologic disease modifying therapy. Arthritis Care & Research 2015; 67:731–736.

Yun H, Delzell E, Saag KG, Kilgore ML, Morrisey MA, Muntner P, Matthews R, Guo L, Wright N, Smith W, Colón-Emeric C, O'Connor CM, Lyles KW, Curtis JR. Fractures and mortality in relation to different osteoporosis treatments. Clinical and Experimental Rheumatology 2015; 33:302-309.

Yun H, Xie F, Delzell E, Chen L, Levitan EB, Lewis JD, Saag KG, Beukelman T, Winthrop K, Baddley JW, Curtis JR. Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy. Annals of the Rheumatic Diseases 2015; 74:1065-1071.

Curtis JR, Chen L, Bharat A, Delzell E, Greenberg JD, Harrold L, Kremer J, Setoguchi S, Solomon DH, Xie F, Yun H. Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research. Arthritis Care & Research (Hoboken) 2014; 66:1790-1798.

Muntner P, Yun H, Sharma P, Delzell E, Kent ST, Kilgore M, Farkouh ME, Vupputuri S, Bittner V, Rosenson RS, Levitan EB, Safford MM . 2014. Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence among patients initiating treatment following a coronary event. American Journal of Cardiology 2014; 114:826-831.

Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, Safford MM, Millan IY, Crowson CS, Curtis JR. The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2014; 73:1301-1308.

Wright N, Looker A, Saag KG, Curtis JR, Delzell E, Randall S, Dawson-Hughes B. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. Journal of Bone and Mineral Research 2014; 29:2520-2526.

Thacker EL, Muntner P, Zhao H, Safford MM, Curtis JR, Delzell E, Bittner V, Brown TM, Levitan EB. Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: a cross-sectional study. BMC Health Services Research 2014 Apr 29; 14(1):195. [Epub ahead of print].

Yun H, Curtis JR, Guo L, Kilgore M, Muntner P, Saag K, Matthews R, Morrisey M, Wright NC, Becker DJ, Delzell E. Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries. BMC Musculoskeletal Disorders 2014 Apr 1; 15(1):112. [Epub ahead of print].

Curtis JR, Yang S, Patkar NM, Chen L, Singh JA, Cannon GW, Mikuls TR, Delzell E, Saag KG, Safford MM, Duvall S, Alexander K, Napalkov P, Winthrop KL, Burton MJ, Kamauu A, Baddley JW. Risk of hospitalized bacterial infections associated with biologic treatment among U.S. Veterans with Rheumatoid Arthritis. Arthritis Care & Research (Hoboken) 2014; 66:990-997.

Becker DJ, Arora T, Kilgore ML, Curtis JR, Delzell E, Saag KG, Yun H, Morrisey MA. Trends in the utilization and outcomes of Medicare patients hospitalized for hip fracture, 2000–2008. Journal of Aging and Health 2014; 26:360-379.

Curtis JR, Wright NC, Xie F, Chen L, Zhang J, Saag KG, Bharat A, Kremer J, Cofield S, Winthrop K, Delzell E. Use of health plan combined with registry data to predict clinical trial recruitment. Clinical Trials 2014; 11(1):96–101.

Baddley JW, Winthrop KL, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR. Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: Results of the Safety Assessment of Biologic ThERapy (SABER) Study. Annals of the Rheumatic Diseases 2014; 73:1942-1948.

Osterman MT, Haynes K, Delzell E, Zhang J, Bewtra M, Brensinger C, Chen L, Xie F, Curtis JR, Lewis JD. Comparative effectiveness of infliximab and adalimumab for Crohn’s disease. Clinical Gastroenterology and Hepatology 2014; 12:811-817

Tajeu G, Delzell E, Smith W, Arora T, Curtis J, Saag K, Morrisey MA, Yun H, Kilgore ML. Death, debility, and destitution following hip fracture. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2014; 69:346-353.

Curtis JR, Xie F, Chen R, Chen L, Kilgore ML, Lewis JD, Yun H, Zhang J, Wright N, Delzell E. Identifying newly approved medications in Medicare claims data: A case study using tocilizumab. Pharmacoepidemiology and Drug Safety 2013; 22:1214-1221.

Zhang J, Xie F, Delzell E, Chen L, Kilgore ML, Yun H, Saag KG, Lewis J, Curtis JR. Trends in the use of biologic therapies among rheumatoid arthritis patients enrolled in the U.S. Medicare program. Arthritis Care & Research 2013; 65:1743–1751.

Zhang J, Delzell E, Curtis JR, Hooven F, Gehlbach SH, Anderson Jr. FA, Saag KG. Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass. Osteoporosis International 2013 Aug 28 [Epub ahead of print].

Winthrop KL, Baddley JW, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. Journal of the American Medical Association 2013; 309:887–895.

Beukelman T, Xie F, Baddley JW, Chen L, Delzell E, Grijalva CG, Mannion ML, Patkar NM, Saag KG, Winthrop KL, Curtis JR. Brief report: Incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis & Rheumatism 2013;65:1384–1389.

Kilgore ML, Curtis JR, Delzell E, Becker DJ, Arora T, Saag KG, Morrisey MA. A close examination of healthcare expenditures related to fractures. Journal of Bone and Mineral Research 2013; 28:816–820.

Yun H, Curtis JR, Saag K, Kilgore M, Muntner P, Smith W, Matthews R, Wright N, Morrisey MA, Delzell E. Generic alendronate use among Medicare beneficiaries: Are Part D data complete? Pharmacoepidemiology and Drug Safety 2013; 22:55–63.

Mudano AS, Gary LC, Oliveira AL, Melton M, Wright NC, Curtis JR, Delzell E, Harrington TM, Kilgore ML, Lewis CE, Singh JA, Warriner AH, Pace WD, Saag KG. Using tablet computers compared to interactive voice response to improve subject recruitment in osteoporosis pragmatic clinical trials: Feasibility, satisfaction, and sample size. Journal of Patient Preference and Adherence 2013; 7:517–523.

Morrisey MA, Kilgore ML, Becker DJ, Smith W, Delzell E. Favorable selection, risk adjustment and the Medicare Advantage Program. Health Services Research 2013; 48:1039–1056.

Winthrop KL, Chen L, Fraunfelder FW, Ku J, Varley C, Suhler E, Hills W, Gattey D, Baddley JW, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Herrinton L, Fraunfelder FT, Saag KG, Lewis JD, Solomon DH, Curtis JR. Initiation of anti-TNF therapy and the risk of optic neuritis; from the Safety Assessment of Biologic ThERapy (Saber) Study. American Journal of Ophthalmology 2013; 155:183–189.

Curtis JR, Sharma P, Arora T, Bharat A, Barnes I, Morrisey M, Kilgore M, Saag, KG, Wright N, Yun H, Delzell E. Physicians’ explanation for apparent gaps in quality of rheumatology care: Results from the U.S. Medicare Physician Quality Reporting System. Arthritis Care & Research 2013; 65:235–243.

Wickremasinghe AR, Peiris-John R, Nandasena S, Delzell E, Tipre M, Sathiakumar N. Capacity building in environmental and occupational health in Sri Lanka. American Journal of Industrial Medicine 2013; 56:1–10.

Sathiakumar N, Delzell E, Morrisey MA, Falkson C, Yong M, Chia V, Blackburn J, Arora T, Kilgore ML. Mortality following bone metastasis and skeletal-related events among patients 65 years and above with lung cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999–2006. Lung India 2013; 30:20–26.

Bhat HV, Kamath R, Arunkumar G, Delzell E, Tipre M, Upadhyay DK, Sathiakumar N. MPH program at Manipal University, India-experiences, challenges, and lessons learned. American Journal of Industrial Medicine 2013; 56:20–28.

Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchell EF, Stein CM, Griffin MR. Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. Arthritis Care & Research 2013; 66:1085–1094.

Zhang J, Xie F, Delzell E, Chen L, Winthrop K, Lewis JD, Saag K, Baddley JW, Curtis JR. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. Journal of the American Medical Association 2012; 308:43–49.

Zhang J, Delzell E, Zhao H, Laster AJ, Saag KG, Kilgore ML, Morrisey MA, Wright NC, Yun H, Curtis JR. Central DXA utilization shifts from office-based to hospital-based settings among Medicare beneficiaries in the wake of reimbursement changes. Journal of Bone and Mineral Research 2012; 27:858–864.

Curtis JR, Xie F, Chen Lang, Muntner P, Spettell C, Fernandes J, Mcmahan RM, Baddley JW, Saag KG, Beukelman T, Grijalva C, Delzell E. Use of a disease risk score to compare serious infections associated with anti-TNF therapy among higher versus lower risk rheumatoid arthritis patients. Arthritis Care & Research 2012; 64:1480–1489.

Wright NC, Curtis JR, Saag KG, Smith W, Kilgore M, Morrisey MA, Yun H, Zhang J, Delzell E. Recent trends in hip fracture rates by race/ethnicity among older US adults. Journal of Bone and Mineral Research 2012; 27:2325–2332.

Curtis J, Yun H, Lange J, Matthews R, Saag KG, Delzell E. Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data. Arthritis Care & Research 2012; 64:1855–1863.

Saag KG, Mohr PD, Esmail L, Wright N, Curtis JR, Cutter G, Delzell E, Gary LC, Lewis CE, Harrington TM, Karkare S, Kilgore ML, Moloney R, Mudano AS, Oliveira A, Singh J, Warriner A, Zhang J, Berger M, Cummings SR, Pace W, Solomon DH, Wallace R, Tunis SR. Improving the efficiency and effectiveness of pragmatic clinical trials in older adults. Contemporary Clinical Trials 2012; 33:1211–1216.

Kilgore M, Smith W, Curtis JR, Morrisey MA, Becker DJ, Saag KG, Delzell E. Evaluating comorbidity scores based on health service expenditures. Medicare Medicaid Research Review 2012; 2(3), E1–E08.

Narongroeknawin P, Patkar NM, Shakoory B, Jain A, Curtis JR, Delzell E, Lander PH, Lopez-Ben RR, Pitt MJ, Safford MM, Volgas DA, Saag KG. Validation of diagnostic codes for subtrochanteric, diaphyseal, and typical hip fractures using administrative claims data. Journal of Clinical Densitometry 2012; 15:92–102.

Bharat A, Xie F, Baddley JW, Beukelman T, Chen L, Calabrese L, Delzell E, Grijalva CG, Patkar N, Saag K, Winthrop K, Curtis JR. Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases. Arthritis Care & Research 2012; 64:612–615.

Sathiakumar N, Delzell E, Morrisey MA, Falkson C, Yong M, Chia V, Blackburn J, Arora T, Brill I, Kilgore M. Mortality following bone metastasis and skeletal-related events among women with breast cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999–2006. Breast Cancer Research and Treatment 2012; 13:231–238.

Beukelman T, Haynes K, Curtis JR, Xie F, Chen L, Bemrich-Stolz, Delzell E, Kim H, Saag KG, Lewis JD. Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis & Rheumatism 2012; 64:1263–1271.

Scarlett HP, Postlethwait E, Delzell E, Sathiakumar N, Oestenstad RK. Asbestos in public hospitals: Are employees at risk? Journal of Environmental Health 2012; 74:22–26.

Curtis JR, Yun H, Matthews R, Saag K, Delzell E. Adherence with intravenous zoledronate and IV ibandronate in the United States Medicare population. Arthritis Care & Research 2012; 64:1054–1060.

Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, Lewis JD, Nourjah P, Ouellet-Hellstrom R, Patkar NM, Saag KG, Winthrop KL, Curtis JR. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis & Rheumatism 2012; 64:2773–2780.

Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, Griffin MR, Herrinton LJ, Liu L, Nourjah P, Ouellet-Hellstrom R, Patkar NM, Solomon DH, Lewis JD, Xie F, Saag KG, Curtis JR. Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. Journal of the American Medical Association 2011; 306(21):2331–2339.

Taylor AJ, Gary LC, Arora T, Becker DJ, Curtis JR, Kilgore ML, Morrisey MA, Saag KG, Matthews R, Yun H, Smith W, Delzell E. Clinical and demographic factors associated with fractures among older Americans. Osteoporosis International 2011; 22:1263–1274.

Warriner A, Patkar N, Curtis JR, Delzell E, Gary L, Kilgore M, Saag KS. Which fractures are most attributable to osteoporosis? Journal of Clinical Epidemiology 2011; 64:46–53.

Curtis J, Delzell E, Chen L, Black D, Ensrud K, Judd S, Palermo L, Safford M, Schwartz A, Bauer D. The relationship between bisphosphonate adherence and fracture: Is it the behavior or the medication? Results from the placebo arm of the Fracture Intervention Trial. Journal of Bone and Mineral Research 2011; 26:683–688.

Curtis J, Xie F, Chen L, Spettell C, Mcmahan RM, Fernandes J, Delzell E. The incidence of gastrointestinal perforations among rheumatoid arthritis patients. Arthritis & Rheumatism 2011; 63:346–351.

Curtis J, Larson JC, Delzell E, Brookhart MA, Cadarette SM, Chlebowski R, Judd S, Safford M, Solomon DH, LaCroix AZ. Placebo adherence, clinical outcomes and mortality in the Women's Health Initiative randomized hormone therapy trials. Medical Care 2011; 49:427–435.

Sathiakumar N, Delzell E, Morrisey MA, Falkson C, Yong M, Chia V, Blackburn J, Arora T, Kilgore M. Mortality following bone metastasis and skeletal-related events among men with prostate cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999–2006. Prostate Cancer and Prostatic Diseases 2011; 14:177–183.

Sathiakumar N, MacLennan PA, Mandel J, Delzell E. A review of epidemiologic studies of triazine herbicides and cancer. Critical Reviews in Toxicology 2011; 41 Suppl 1:1–34.

Zhang J, Yun H, Wright NC, Kilgore M, Delzell E. Potential and pitfalls of large administrative data sets to study safety of anti-osteoporosis therapies. Current Rheumatology Reports 2011; 13:273–282.

Baddley JW, Winthrop KL, Patkar NM, Delzell E, Beukelman T, Xie F, Chen L, Curtis JR. Geographic distribution of endemic fungal infections among older Americans. Emerging Infectious Disease 2011; 17:1664– 1669.

Curtis J, Xie F, Chen L, Baddley J, Beukelman T, Saag K, Spettell C, McMahan RM, Fernandes J, Winthrop K, Delzell E. The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents. Annals of the Rheumatic Diseases 2011; 70:1401–1406.

Kawai V, Grijalva C, Arbogast P, Curtis J, Solomon D, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchell E, Stein CM, Griffin MR. Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis. Arthritis Care & Research 2011; 63:1415–1424.

Herrinton LJ, Curtis JR, Chen L, Liu L, Delzell E, Lewis JD, Solomon DH, Griffin MR, Ouellet-Hellstrom R, Beukelman T, Grijalva CG, Haynes K, Kuriya B, Lii J, Mitchel E, Patkar N, Rassen J, Winthrop KL, Haynes K, Nourjah P, Saag KG. Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Pharmacoepidemiology and Drug Safety 2011; 20:1199–1209.

Warriner A, Patkar NM, Yun H, Delzell E. Minor, major, low-trauma, and high-trauma fractures: What are the subsequent fracture risks and how do they vary? Current Osteoporosis Reports 2011; 9:122–128.

Curtis JR, Baddley J, Yang S, Patkar N, Chen L, Delzell E, Mikuls TR, Saag K, Singh J, Safford M, Cannon GW. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis. Arthritis Research & Therapy 2011 Sep 20; 13:R155.

Zhang J, Delzell E, Xie F, Baddley JW, Spettell C, McMahan RM, Fernandes J, Chen L, Winthrop K, Curtis JR. The use, safety and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: A longitudinal observational study. Arthritis Research & Therapy 2011; 13:R174.

Becker DJ, Yun H, Kilgore ML, Morrisey MA, Gary LC, Curtis JR, Saag KG, Matthews R, Smith W, Taylor A, Arora T, Delzell E. Health services utilization after fractures: Recent evidence from Medicare. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2010; 65:1012–1020.

Scarlett HP, Delzell E, Sathiakumar N, Oestenstad RK, Postlethwait E. Knowledge, attitudes and practices of hospital employees with respect to asbestos, its potential health hazards and management. Journal of Environmental Health Research 2010; 10:7–16.

Scarlett HP, Delzell E, Sathiakumar N, Oestenstad RK, Postlethwait E. Exposure to airborne asbestos in Journal of the American Medical Association hospitals. West Indian Medical Journal 2010; 59:668–673.

Curtis J, Arora T, Matthews RS, Taylor A, Becker DJ, Colon-Emeric C, Kilgore ML, Morrisey MA, Saag KG, Safford MM, Warriner A, Delzell E. Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. Journal of the American Medical Directors Association 2010; 11:584–591.

Yun H, Kilgore ML, Curtis JR, Delzell E, Gary LC, Saag KG, Morrisey MA, Becker D, Matthews R, Smith W, Locher JL. Identifying types of nursing facility stays using Medicare claims data: an algorithm and validation. Health Services and Outcomes Research Methodology 2010; 10:100–110.

Yun H, Delzell E, Ensrud KE, Kilgore D, Morrisey MA, Curtis JR. Predicting hip and major osteoporotic fractures using administrative data. (Research letter) Archives of Internal Medicine 2010; 170:1940–1942.

Curtis JR, Arora T, Narongroeknawin P, Taylor AJ, Bingham CO, Cush JJ, Saag K, Safford M, Delzell E. The delivery of evidence-based preventive care for older Americans with arthritis. Arthritis Research & Therapy 2010; 12:R144.

Delzell E, Haag G. (Letter) Comments on results of Scher et al. pertaining to nonprescription caffeine-containing combination analgesics. Cephalalgia 2010; 30:1145–1146.

Taylor AJ, Gary LC, Arora T, Becker DJ, Curtis JR, Kilgore ML, Morrisey MA, Saag KG, Matthews R, Yun H, Smith W, Delzell E. Erratum to: Clinical and demographic factors associated with fractures among older Americans. Osteoporosis International 2010;1–2.

Curtis JR, Laster AJ, Becker DJ, Carbone L, Gary LC, Kilgore ML, Matthews R, Morrisey MA, Saag KG, Tanner SB, Delzell E. The geographic availability and associated utilization of dual energy X-ray absorptiometry (DXA) testing among older persons in the United States. Osteoporosis International 2009; 20:1553–1561.

Curtis JR, Westfall AO, Cheng H, Saag KG, Delzell E. RisedronatE and ALendronate investigation over three years (REALITY): Minimal differences in fracture risk reduction. Osteoporosis International 2009; 20:973–978.

Curtis JR, Xi J, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E. Improving the prediction of medication compliance: The example of bisphosphonates for osteoporosis. Medical Care 2009; 47:334–341.

Haricharan RN, Barnhart DC, Cheng H, Delzell E. Identifying neonates at a very high risk for mortality among children with congenital diaphragmatic hernia managed with extracorporeal membrane oxygenation. Journal of Pediatric Surgery 2009; 44:87–93.

Janjua NZ, Delzell E, Larson RR, Meleth S, Kristensen S, Kabagambe E, Sathiakumar N. Determinants of low birth weight in urban Pakistan. Public Health Nutrition 2009; 12:789–798.

Kilgore ML, Morrisey MA, Becker DL, Gary LC, Curtis JR, Saag KG, Yun H, Matthews RS, Smith W, Taylor A, Arora T, Delzell E. Health care expenditures associated with skeletal fractures among Medicare beneficiaries, 1999–2005. Journal of Bone and Mineral Research 2009; 24:2050–2055.

Curtis JR, Taylor A, Matthews R, Ray MR, Becker DJ, Gary LC, Kilgore ML, Morrisey MA, Saag KG, Warriner A, Delzell E. “Pathologic” fractures: Should these be included in epidemiologic studies of osteoporotic fractures? Osteoporosis International 2009; 20:1969–1972.

Cheng H, Gary LC, Curtis JR, Saag KG, Kilgore ML, Matthews RS, Morrisey MA, Smith W, Yun H, Delzell E. Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data. Osteoporosis International 2009; 20:1507–1515.

Graff JJ, Sathiakumar N, Macaluso M, Maldonado G, Matthews R, Delzell E. The effect of uncertainty in exposure estimation on the exposure-response relation between 1,3-butadiene and leukemia. International Journal of Environmental Research and Public Health 2009; 6:2436–2455.

Curtis JR, McClure LA, Delzell E, Howard VJ, Orwoll E, Saag KG, Safford M, Howard G. Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. Journal of General Internal Medicine 2009; 24:956-962.

Sathiakumar N, Delzell E. A follow-up study of mortality among women in the North American synthetic rubber industry. Journal of Occupational and Environmental Medicine 2009; 51:1314-1325.

Sathiakumar N, Brill I, Delzell E. 1,3-Butadiene, styrene and lung cancer among synthetic rubber industry workers. Journal of Occupational and Environmental Medicine 2009;51(11):1326-1332.

Curtis JR, Carbone L, Cheng H, Hayes B, Laster A, Matthews RS, Saag KG, Sepanski R, Tanner SB, Delzell E. Longitudinal trends in use of bone mass measurement among older Americans, 1999-2005. Journal of Bone and Mineral Research 2008; 23:1061-1067.

Curtis JR, Cheng H, Delzell E, Fram D, Kilgore M, Saag K, Yun H, DuMouchel W. Adaptations of Bayesian data mining algorithms to longitudinal claims data: Coxib safety as an example. Medical Care 2008; 46:969-975.

Curtis JR, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E. Benefit of adherence with bisphosphonates depends on age and fracture type: Results from an analysis of 101,038 new bisphosphonate users. Journal of Bone and Mineral Research 2008; 23:1435-1441.

Curtis JR, Westfall AO, Cheng H, Delzell E, Saag KG. Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday. Osteoporosis International 2008; 19:1613-1620.

Janjua NZ, Delzell E, Larson RR, Meleth S, Kabagambe E, Kristensen S, Sathiakumar N. Maternal nutritional status during pregnancy and surma use determine cord blood lead levels in Karachi Pakistan. Environmental Research 2008; 108:69-79.

Curtis JR, Laster AJ, Becker DJ, Carbone L, Gary LC, Kilgore ML, Matthews R, Morrisey MA, Saag KG, Tanner SB, Delzell E. Regional variation in the denial of reimbursement for bone mineral density testing among US Medicare beneficiaries. Journal of Clinical Densitometry 2008; 11:568-574.

Bender TJ, Beall C, Cheng H, Herrick RF, Kahn AR, Matthews R, Sathiakumar N, Schymura MJ, Stewart JH, Delzell E. Cancer incidence among employees at semiconductor and storage device manufacturing facilities. Occupational and Environmental Medicine 2007; 64:30-36.

Sathiakumar N, Cheng H, Lynch J, Sparks B, Macaluso M, Delzell E. Validation of 1,3-butadiene exposure estimates for workers at a synthetic rubber plant. Chemico-biological Interactions 2007; 166:29-43.

Sielken Jr RL, Valdez-Flores C, Gargas ML, Kirman CR, Teta MJ, Delzell E. Cancer risk assessment for 1,3-butadiene: dose-response modeling from an epidemiological perspective. Chemico-biological Interactions 2007; 166:140-149.

Cheng H, Sathiakumar N, Graff J, Matthews R, Delzell E. 1,3-Butadiene and Leukemia Among Synthetic Rubber Industry Workers: Exposure-Response Relationships. Chemico-biological Interactions 2007; 166:15-24.

Sathiakumar N, Delzell E. A follow-up study of women in the synthetic rubber industry: Study methods. Chemico-biological Interactions 2007; 166(1-3):25-28, 2007.

Beall C, Corn M, Cheng H, Matthews R, Delzell E. Mortality and cancer incidence among tire manufacturing workers hired in or after 1962. Journal of Occupational and Environmental Medicine 2007; 49:680-90.

Glasser S, Salas M, Delzell E. Importance and challenges of studying marketed drugs: what is a phase IV (4) study? Journal of Clinical Pharmacology 2007; 47:1074-1086.

Bender TJ, Beall C, Cheng H, Herrick RF, Kahn AR, Matthews R, Sathiakumar N, Schymura MJ, Stewart JH, Delzell E. Methodologic issues in follow-up studies of cancer incidence among occupational groups in the United States. Annals of Epidemiology 2006; 16:170-179.

Cheng H, Aylward LL, Beall C, Starr TB, Brunet RC, Carrier G, Delzell E. TCDD Exposure-Response Analysis and Risk Assessment. Risk Analysis2006; 26:1059-1071.

Delzell E, Sathiakumar N, Graff J, Macaluso M, Maldonado G, Matthews R. An updated study of mortality among North American synthetic rubber industry workers. Research Reports of the Health Effects Institute. Aug;(132):1-63, 2006.

Sathiakumar N, Janjua NZ, Kadir M, Spokes AM, White H, Kristensen S, Delzell E. From conflict to collaboration, local political climate accelerates ITREOH's regionalization in South Asia. International Journal of Occupational and Environmental Health 2006; 12:386-391.

Ali S, Sathiakumar N, Delzell E. Prevalence and socio-demographic factors associated with tobacco smoking among adult males in rural Sindh, Pakistan. Southeast Asian Journal of Tropical Medicine and Public Health 2006; 37:1054-60.

Graff J, Sathiakumar N, Macaluso M, Maldonado G, Matthews R, Delzell E. Chemical exposures in the synthetic rubber industry and lymphohematopoietic cancer mortality. Journal of Occupational and Environmental Medicine 2005; 47:916-932.

Herrick RF, Stewart JH, Blicharz D, Beall C, Bender T, Cheng H, Matthews R, Sathiakumar N, Delzell E. Exposure assessment for retrospective follow-up studies of semiconductor and storage device manufacturing workers. Journal of Occupational and Environmental Medicine 2005; 47:983-995.

Beall C, Bender TJ, Cheng H, Herrick RF, Kahn AR, Matthews R, Sathiakumar N, Schymura MJ, Stewart JH, Delzell E. Mortality among semiconductor and storage device manufacturing workers. Journal of Occupational and Environmental Medicine 2005; 47:996-1014.

Sathiakumar N, Graff J, Macaluso M, Maldonado G, Matthews R, Delzell E. An updated study of mortality among North American synthetic rubber industry workers. Occupational and Environmental Medicine 2005; 62:822-829.

Aylward LL, Brunet RC, Starr TB, Carrier G, Delzell E, Cheng H, Beall C. Exposure reconstruction for the TCDD-exposed NIOSH cohort using a concentration- and age-dependent model of elimination. Risk Analysis 2005; 25:945-956.

Delzell E, Sathiakumar N, Graff J, Matthews R. Styrene and ischemic heart disease mortality among synthetic rubber industry workers. Journal of Occupational and Environmental Medicine 2005; 47:1235-1243.

Macaluso M, Larson R, Lynch J, Lipton S, Delzell E. Historical estimation of exposure to 1,3-butadiene, styrene, and dimethyldithiocarbamate among synthetic rubber workers. Journal of Occupational and Environmental Health 2004; 1:371-390.

Casanova M, Cole P, Collins JJ, Conolly R, Delzell E, et al. (Letter) re: Mortality from lymphohematopoietic malignancies among workers employed in formaldehyde industries. Journal of the National Cancer Institute 2004; 96:966-967.

Sathiakumar N, Delzell E, MacLennan PA, Anne M, Rosenberg NL, Cheng H, Myers S. A cross-sectional study of triallate exposure and neurological health among workers at a pesticide manufacturing and formulating facility. Occupational and Environmental Medicine 2004; 61:936-944.

Acquavella JF, Delzell E, Cheng H, Lynch CF, Johnson G. Mortality and cancer incidence among alachlor manufacturing workers 1968-1999. Occupational and Environmental Medicine 2004; 61:680-685.

MacLennan P, Delzell E, Myers S. Mortality among workers at a triazine herbicide manufacturing plant. Journal of Toxicology and Environmental Health A 2003; 66:501-517.

Maldonado G, Delzell E, Tyl RW, Sever LE. Occupational exposure to glycol ethers and human congenital malformations. International Archives of Occupational and Environmental Health 2003; 76:405-423.

Delzell E, Brown DA, Matthews R. Mortality among hourly motor vehicle manufacturing workers. Journal of Occupational and Environmental Medicine 2003; 45:813-830.

Cohen JT, Carlson G, Charnley G, Coggon D, Delzell E, et al. (Panel Report) A comprehensive evaluation of the potential health risks associated with occupational and environmental exposure to styrene. Journal of Toxicology and Environmental Health B Critical Reviews 2002; 5:1-265.

Honda Y, Beall C, Delzell E, Oestenstad K, Brill I, Matthews R. Mortality among workers at a talc mining and milling facility. Annals of Occupational Hygiene 2002; 46:575-585.

Oestenstad K, Honda Y, Delzell E, Brill I. Assessment of historical exposures to talc at a mining and milling facility. Annals of Occupational Hygiene 2002; 46:587-596.

MacLennan P, Delzell E, Sathiakumar N, Myers S, et al. Cancer incidence among triazine herbicide manufacturing workers. Journal of Occupational and Environmental Medicine 2002; 44:1048-1058.

Lynch BS, Delzell E, Bechtel DH, Buchner B. Resorcinol: Toxicology review and risk assessment. Regulatory Toxicology and Pharmacology 2002; 36:198-210.

Sathiakumar N, Delzell E, Cole P. Mortality among workers at a plastics manufacturing plant. Journal of Environmental Medicine 1999; 1:241-248.

Rodu B, Delzell E, Beall C, Sathiakumar N. Mortality among employees at a petrochemical research facility. American Journal of Industrial Medicine 2001; 39:29-41.

Sathiakumar N, Delzell E, Beall C, Rodu B. Cancer incidence among employees at a petrochemical research facility. Journal of Occupational and Environmental Medicine 2001; 43:166-174.

Delzell E, Macaluso M, Sathiakumar N, Matthews R. Leukemia and exposure to 1,3-butadiene, styrene and dimethyldithiocarbamate among workers in the synthetic rubber industry. Chemico-biological Interactions 2001; 135-136:515-534.

Beall C, Delzell E, Rodu B, Sathiakumar N, Myers S. Cancer and benign tumor incidence among employees at a polymers research complex. Journal of Occupational and Environmental Medicine 2001; 43:914-924.

Beall C, Delzell E, Rodu B, Sathiakumar N, Lees PSF, Breysse PN, Myers S. Case-control study of intracranial tumors among employees at a petrochemical research facility. Journal of Occupational and Environmental Medicine 2001; 43:1103-1113.

Delzell E. (Invited comment) The chemical industry's impact on the health of its workers Epidemiology 2001; 12:602-603.

Velentgas P, Delzell E, Toeppen-Sprigg B, Holtshouser JL. (Letter) Response to: Mortality among rubber chemical manufacturing workers by M.M. Prince et al. American Journal of Industrial Medicine 2001; 40:393-396.

Cole P, Delzell E, Rodu B. Moneychangers in the temple. Epidemiology 11:84-90, 2000. Gray GM, Goldstein, BD, Bailar J, Davis DL, Delzell E, et al. (Panel Report) The Federal Government's Agricultural Health Study. a critical review with suggested improvements. Human Ecology and Risk Assessment 2000; 6:47-71.

Sathiakumar N, Delzell E. An updated mortality study of workers at a dye and resin manufacturing plant. Journal of Occupational and Environmental Medicine 2000; 42:762-771.

Brown D, Delzell E. A nested case-control study of motor vehicle manufacturing and prostate cancer. American Journal of Industrial Medicine 2000; 38:59-70.

Feinstein AR, Heinemann LAJ, Curhan GC, Delzell E, et al. (Panel Report) The relationship between non-phenacetin combined analgesics and nephropathy. A review. Kidney International 2000; 58:2259-2264.

Bach PB, Berndt WO, Delzell E, et al. (Panel Report) A safety assessment of fixed combinations of acetaminophen and acetyl-salicylic acid, coformulated with caffeine. Renal Failure 1999; 20:749-762.

Delzell E, Beall C, Rodu B, et al. A case-series investigation of intracranial neoplasms at a petrochemical research facility. American Journal of Industrial Medicine 1999; 36:450-458.

Maldonado G, Delzell E, Poole C. (Abstract) A unified approach to conducting and interpreting occupational studies of congenital malformations. American Journal of Epidemiology 1999; 149:S59.

Munro IC, Delzell E, Nestmann ER, Lynch BS. Viadent usage and oral leukoplakia. a spurious association. Regulatory Toxicology and Pharmacology 1999; 30:182-196.

Delzell E, Shapiro S. A review of epidemiologic studies of nonnarcotic analgesics and chronic renal disease. Medicine 1998; 77:102-121.

Sathiakumar N, Delzell E, Hovinga M, et al. Mortality from cancer and other causes of death among synthetic rubber workers. Occupational and Environmental Medicine 1998; 55:230-235.

Sathiakumar N, Delzell E, Abdalla O. Using the National Death Index to obtain underlying cause of death codes. Journal of Occupational and Environmental Medicine 1998; 40:808-813.

Austin H, Delzell E, Day-Lally C, et al. A case-control study of lung cancer at a foundry and two engine plants. American Journal of Industrial Medicine 1997; 31:414-421.

Sathiakumar N, Delzell E, Amoateng-Adjepong Y, Larson R, Cole P. Epidemiologic evidence on the relationship between mists containing sulfuric acid and respiratory tract cancer. Critical Reviews in Toxicology 1997; 27:233-251.

Sathiakumar N, Delzell E. A review of epidemiologic studies of triazine herbicides and cancer. Critical Reviews in Toxicology 1997; 27:599-613.

Delzell E. Beyond social class. (Editorial) Epidemiology 1996; 7:1-3.

Sathiakumar N, Delzell E, Cole P. Mortality among workers at two triazine herbicide manufacturing plants. American Journal of Industrial Medicine 1996; 29:143-151.

Beall C, Delzell E, Cole P, Brill I. Brain tumors among electronics industry employees. Epidemiology 1996; 7:125-130.

Delzell E, Sathiakumar N, Hovinga M, et al. A follow-up study of synthetic rubber workers. Toxicology 1996; 113:182-189.

Macaluso M, Larson R, Delzell E, et al. Leukemia and cumulative exposure to butadiene, styrene and benzene among workers in the synthetic rubber industry. Toxicology 1996; 113:190-202.

Delzell E, Shapiro S. A commentary on National Kidney Foundation position paper on analgesics and the kidney. American Journal of Kidney Disease 1996; 28:783-785.

Amoateng-Adjepong Y, Sathiakumar N, Delzell E, Cole P. Mortality among workers at a pesticide manufacturing plant. Journal of Occupational and Environmental Medicine 1995; 37:471-478.

Honda Y, Delzell E, Cole P. An updated study of mortality among workers at a petroleum manufacturing plant. Journal of Occupational and Environmental Medicine 1995;37:194-200.

Cole P, Sateren W, Delzell E. Epidemiologic perspectives on myelodysplastic syndromes and leukemia. Leukemia Research 1995; 19:361-365.

Beall C, Delzell E, Macaluso M. Mortality patterns among women in the motor vehicle manufacturing industry. American Journal of Industrial Medicine 1995; 28:325-337.

Sathiakumar N, Delzell E, Cole P, et al. A case-control study of leukemia among petroleum workers. Journal of Occupational and Environmental Medicine 1995; 37:1269-1277.

Delzell E. Wood dust and formaldehyde. IARC Monographs on the evaluation of carcinogenic links to humans. Volume 62. (Review) Cancer Causes and Control 1995; 6:574-575.

Barbone F, Delzell E, Austin H, Cole P. Exposure to epichlorohydrin and central nervous system neoplasms at a resin and dye manufacturing plant. Archives of Environmental Health 1994; 49:355-358.

Delzell E, Beall C, Macaluso M. Cancer mortality among women employed in motor vehicle manufacturing. Journal of Occupational Medicine 1994; 36:1251-1254.

Macaluso M, Delzell E, Rose V, et al. Use of organic solvents and potential worker exposure in the motor vehicle manufacturing industry. American Journal of Industrial Medicine 1993; 23:449-460.

Cole P, Delzell E, Acquavella J. Exposure to butadiene and lymphatic and hematopoietic cancer. Epidemiology 1993; 4:96-103.

Macaluso M, Delzell E, Rose V, et al. Inter-rater agreement in the assessment of solvent exposure at a car assembly plant. American Industrial Hygiene Association Journal 1993; 54:351-359.

Rotimi C, Austin H, Delzell E, et al. A retrospective follow-up study of foundry and engine plant workers. American Journal of Industrial Medicine 1993; 24:485-498.

Delzell E, Macaluso M, Honda Y, et al. Mortality patterns among men in the motor vehicle manufacturing industry. American Journal of Industrial Medicine 1993; 24:471-484.

Sathiakumar N, Delzell E, Cole P, Austin H. A follow-up study of agricultural chemical production workers. American Journal of Industrial Medicine 1992; 21:321-330.

Barbone F, Delzell E, Austin H, Cole P. A case-control study of lung cancer at a dye and resin manufacturing plant. American Journal of Industrial Medicine 1992; 22:835-849.

Macaluso M, Delzell E, Cole P, Cowles S. An evaluation of a corporate health surveillance system. Journal of Occupational Medicine 1991; 33:1180-1186.

Wongsrichanalai C, Delzell E, Cole P. Mortality from leukemia and other diseases among workers at a petroleum refinery. Journal of Occupational Medicine 1989; 31:106-111.

Delzell E, Macaluso M, Cole P. A follow-up study of mortality among chemical workers. Journal of Occupational Medicine 1989; 31:273-278.

Grufferman S, Cohen HJ, Delzell ES, et al. Familial aggregation of multiple myeloma and central nervous system diseases. Journal of the AmericanGeriatrics Society 1989; 37:303-309.

Austin H, Delzell E, Cole P. Benzene and leukemia. A review of the literature and a risk assessment. Americal Journal of Epidemiology 1988; 127:419-439.

Schumacher MC, Delzell E. A death certificate case-control study of non-Hodgkin's lymphoma and occupation in men in North Carolina. American Journal of Industrial Medicine 1988; 13:317-330.

Waterbor J, Cole P, Delzell E, Andjelkovich D. The mortality experience of major-league baseball players. New England Journal of Medicine 1988; 318:1278-1280.

Austin H, Delzell E, Grufferman S, et al. A case-control study of hepatocellular carcinoma, occupation, and chemical exposures. Journal of Occupational Medicine 1987; 29:665-669.

Austin H, Delzell E, Grufferman S, et al. A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Research 1986; 46:962-966.

Lanes SF, Delzell E, Dreyer NA, Rothman KJ. Analgesics and kidney disease. International Journal of Epidemiology 1986; 15:454-455.

Delzell E, Grufferman S. Mortality among white and nonwhite farmers in North Carolina, 1976-1978. American Journal of Epidemiology 1985; 121:391402.

Delzell E, Monson RR. Mortality among rubber workers. X. Reclaim workers. American Journal of Industrial Medicine 1985; 7:307-313.

Bourguet CC, Grufferman S, Delzell E, et al. Multiple myeloma and family history of cancer. A case control study. Cancer 1985; 65:2133-2139.

Delzell E, Monson RR. Mortality among rubber workers. IX. Curing workers. American Journal of Industrial Medicine 1985; 8:537-544.

Johnston JM, Grufferman S, Bourguet CC, Delzell E, et al. Socioeconomic status and risk of multiple myeloma. Journal of Epidemiology and Community Health 1985; 39:175-178.

Wagner RF, Pellegrini JR, Delzell E. Decreased risk of subsequent primary noncutaneous malignancies among patients with primary cutaneous malignant melanoma. Journal of Dermatologic Surgery and Oncology 1985; 11:1097-1102.

Olsen EA, Delzell E, Jegasothy BV. Second malignancies in cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology 1984; 10:197-204.

Delzell E, Monson RR. Mortality among rubber workers. VIII. Industrial products workers. American Journal of Industrial Medicine 1984; 6:273-279.

Delzell E, Monson RR. Mortality among rubber workers. VII. Aerospace workers. American Journal of Industrial Medicine 1984; 6:265-271.

Capps JL, Delzell E, Bourguet CC, et al. (Letter) Causes of neonatal mortality, Journal of the American Medical Association 1984; 252:1853-1854.

Grufferman S, Delzell E. Epidemiology of Hodgkin's disease. Epidemiology Reviews Vol 6, 1984.

Grufferman S, Delzell ES, Delong ER, Maile MC. An approach to conducting epidemiologic research within cooperative clinical trials groups. Journal of Clinical Oncology 1984; 2:670-675.

Delzell E, Grufferman S. Cancer and other causes of death among female textile workers, 1976-78. Journal of the National Cancer Institute 1983; 71:735-740.

Grufferman S, Delzell ES, Maile MC, Michalopoulos G. Parents' cigarette smoking and childhood cancer. Medical Hypotheses 1983; 12:17-20.

Grufferman S, Wang HH, DeLong ER, Kimm SYS, Delzell ES, Falletta JM. Environmental factors in the etiology of rhabdomyosarcoma in childhood. Journal of the National Cancer Institute 1982; 68:107-113.

Delzell E, Monson RR. Mortality among rubber workers. VI. Men with potential exposure to acrylonitrile. Journal of Occupational Medicine 1982; 24:767769.

Delzell E, Monson RR. Mortality among rubber workers. V. Processing workers. Journal of Occupational Medicine 1982; 24:539-545.

Delzell E, Andjelkovich D, Tyroler H. A case-control study of employment experience and lung cancer among rubber workers. American Journal of Industrial Medicine 1982; 3:393-404.

Delzell E, Monson RR. Mortality among rubber workers IV. General mortality patterns. Journal of Occupational Medicine 1981; 23:850-856.

Delzell E, Monson RR. Mortality among rubber workers III. Cause-specific mortality, 1940-1978. Journal of Occupational Medicine 1981; 23:677-684.

Delzell E, Louik C, Lewis J, Monson RR. Mortality and cancer morbidity among workers in the rubber tire industry. American Journal of Industrial Medicine 1981; 2:209-216.

Book Chapters and Other

Glasser SP, Delzell E, Salas M. Phase 4 (Postmarketing) Research. In (SP Glasser, ed) Essentials of Clinical Research. Second Edition. Dordrecht: Springer, 2014, pp 91-116.

Glasser SP, Delzell E, Salas M. Postmarketing Research. In (SP Glasser, ed) Essentials of Clinical Research. Dordrecht: Springer, 2008, pp 73-91.

Delzell E. Epidemiology. In (J. Perkins, ed) Modern Industrial Hygiene, Volume 2. Biological Aspects. Cincinnati, Ohio: ACGIH, 2003, pp 495–552.

Delzell E, Austin H, Cole P. Epidemiologic studies of the petroleum industry. Occupational Medicine. State of the Art Reviews, Vol 3, 1988.

Delzell E. Critical evaluation of epidemiological studies of analgesics and renal disease, with an overview of methodological issues. In Analgesics and renal disease: Who is at risk? (International Congress and Symposium Series, no. 96), C. Wood, ed. London. Royal Society of Medicine Services, 1985.

Monson RR, Delzell E. An estimate of the percentage of occupational cancer among a group of rubber workers. In: Quantification of Occupational Cancer. Peto R. and Schneiderman M (eds), Banbury Report, Cold Spring Harbor, New York: Cold Spring Laboratory, 1981.

Prior Experience

Senior Scientist, Comprehensive Arthritis, Musculoskeletal and Autoimmunity Center (CAMAC) University of Alabama at Birmingham, 2012–2013

Senior Scientist, Center for Education and Research on Therapeutics School of Medicine, University of Alabama at Birmingham, 2007–2013

Senior Scientist, Nephrology Research and Training Center (NRTC) School of Medicine, University of Alabama at Birmingham, 2005–2013

Senior Scientist, UAB Comprehensive Cancer Center, School of Medicine, University of Alabama at Birmingham, 1991–2013

Professor, Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, 1991–2013

Visiting Scientist, ERI (Ingenix), 1999–2000

Associate Professor, Department of Epidemiology, UAB-SPH, 1987–1991

Assistant Professor, Department of Epidemiology, UAB-SPH, 1984–1987

Assistant Professor, Department of Community and Family Medicine and Comprehensive Cancer Center, Duke University, 1981–1984

Teaching Fellow, Department of Epidemiology, Harvard School of Public Health, 1979–1980

Professional Affiliations

Centocor golimumab [GO-SAVE] (DSMB member), 2010–

Member, ATSDR, CDC, Advisory Group, Studies at Camp Lejeune, 2008–

Member, Scientific Advisory Panel, University of Otago (New Zealand), Trichlorophenol Study, 2007–2008

Invited Expert, International Agency for Research on Cancer Working Group 3, 2007

Reviewer, CDC/NIOSH Site Visit and Review Work Group, 2007

Member, Health Effects Institute, Air Toxics Special Review Panel, 2005–2007

Member, National Toxicology Program Board of Scientific Counselors, 2003–2006

Member, Science Advisory Committee, Analgesics and Nephropathy Study in Germany and Austria, 1999–2006

Reviewer, National Institute of Health, Epidemiology of Infectious, Reproductive, Asthma, and Other Pulmonary Disease, 2005

Member, Scientific Advisory Group, LTR/Shell Study, 2002–2003

Member, Scientific Advisory Committee, Chevron Study, 2001–2003

Member, Scientific Advisory Group, LTR/Exxon Study, 2001

Member Harvard Center for Risk Analysis Panel on Styrene, 1999–2000

Scientific Advisor, ILSI Health and Environmental Sciences Institute, Emerging Issues Committee, 1997–2000

Additional Information

Advisory Appointments

Centocor golimumab [GO-SAVE] (DSMB member), 2010–

Member, ATSDR, CDC, Advisory Group, Studies at Camp Lejeune, 2008–

Member, Scientific Advisory Panel, University of Otago (New Zealand), Trichlorophenol Study, 2007–2008

Invited Expert, International Agency for Research on Cancer Working Group 3, 2007

Reviewer, CDC/NIOSH Site Visit and Review Work Group, 2007

Member, Health Effects Institute, Air Toxics Special Review Panel, 2005–2007

Member, National Toxicology Program Board of Scientific Counselors, 2003–2006

Member, Science Advisory Committee, Analgesics and Nephropathy Study in Germany and Austria, 1999–2006

Reviewer, National Institute of Health, Epidemiology of Infectious, Reproductive, Asthma, and Other Pulmonary Disease, 2005

Member, Scientific Advisory Group, LTR/Shell Study, 2002–2003

Member, Scientific Advisory Committee, Chevron Study, 2001–2003

Member, Scientific Advisory Group, LTR/Exxon Study, 2001

Member Harvard Center for Risk Analysis Panel on Styrene, 1999–2000

Scientific Advisor, ILSI Health and Environmental Sciences Institute, Emerging Issues Committee, 1997–2000

Knowledge

CREDENTIALS & PROFESSIONAL HONORS

  • Sc.D., Epidemiology, Harvard University, 1981
  • M.S.P.H., Epidemiology, University of North Carolina, Chapel Hill, 1977
  • B.S., Biology, Oakland University, 1974